(1S,7S,9S,10S,14R,15S,19S)-15-[(2R,5S)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-14-methyl-4-phenyl-7-[(2R,5S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione
C47H69NO10 — CID 154031113
Data last refreshed: (MolForge compound catalog, from PubChem)
About (1S,7S,9S,10S,14R,15S,19S)-15-[(2R,5S)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-14-methyl-4-phenyl-7-[(2R,5S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione
(1S,7S,9S,10S,14R,15S,19S)-15-[(2R,5S)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-14-methyl-4-phenyl-7-[(2R,5S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione (PubChem CID 154031113) has the molecular formula C47H69NO10 and a molecular weight of 808.07 g/mol. Its IUPAC name is (1S,7S,9S,10S,14R,15S,19S)-15-[(2R,5S)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-14-methyl-4-phenyl-7-[(2R,5S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione.
Molecular Properties
| Compound Name | (1S,7S,9S,10S,14R,15S,19S)-15-[(2R,5S)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-14-methyl-4-phenyl-7-[(2R,5S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione |
|---|---|
| PubChem CID | 154031113 |
| Molecular Formula | C47H69NO10 |
| Molecular Weight | 808.07 g/mol |
| Exact Mass | 807.49 |
| IUPAC Name | (1S,7S,9S,10S,14R,15S,19S)-15-[(2R,5S)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-14-methyl-4-phenyl-7-[(2R,5S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione |
| SMILES | CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)C)C(C)O2)[C@@H](C)C(=O)C2=C[C@@H]3C(C=C(c4ccccc4)C4C[C@@H](O[C@@H]5OC(C)[C@H](OC)C(OC)C5OC)C[C@H]43)[C@@H]2CC(=O)O1 |
| InChI | InChI=1S/C47H69NO10/c1-10-30-17-14-18-40(58-42-20-19-39(48(5)6)27(3)54-42)26(2)43(50)38-24-36-34-22-31(57-47-46(53-9)45(52-8)44(51-7)28(4)55-47)21-33(34)32(29-15-12-11-13-16-29)23-35(36)37(38)25-41(49)56-30/h11-13,15-16,23-24,26-28,30-31,33-37,39-40,42,44-47H,10,14,17-22,25H2,1-9H3/t26-,27?,28?,30+,31-,33?,34-,35?,36+,37+,39+,40+,42+,44+,45?,46?,47+/m1/s1 |
| InChIKey | SXFQSDUWCJCDFW-FONQOGDYSA-N |
| XLogP | 7.01 |
| TPSA | 111.22 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 58 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 808.07 |
| LogP ≤ 5 | 7.01 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154031113 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.